These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24553473)

  • 21. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Wood JC; Cohen AR; Pressel SL; Aygun B; Imran H; Luchtman-Jones L; Thompson AA; Fuh B; Schultz WH; Davis BR; Ware RE;
    Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
    Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
    Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
    Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
    Cheong JW; Kim HJ; Lee KH; Yoon SS; Lee JH; Park HS; Kim HY; Shim H; Seong CM; Kim CS; Chung J; Hyun MS; Jo DY; Jung CW; Sohn SK; Yoon HJ; Kim BS; Joo YD; Park CY; Min YH;
    Transfusion; 2014 Jun; 54(6):1542-51. PubMed ID: 24313463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial.
    Wood JC; Pressel S; Rogers ZR; Odame I; Kwiatkowski JL; Lee MT; Owen WC; Cohen AR; St Pierre T; Heeney MM; Schultz WH; Davis BR; Ware RE;
    Am J Hematol; 2015 Sep; 90(9):806-10. PubMed ID: 26087998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of plasma transferrin receptor, ferritin and inflammatory markers in children with sickle cell disease.
    Al-Saqladi AW; Bin-Gadeem HA; Brabin BJ
    Paediatr Int Child Health; 2012 Feb; 32(1):27-34. PubMed ID: 22525445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.
    Deugnier Y; Turlin B; Ropert M; Cappellini MD; Porter JB; Giannone V; Zhang Y; Griffel L; Brissot P
    Gastroenterology; 2011 Oct; 141(4):1202-11, 1211.e1-3. PubMed ID: 21741344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
    Wu SF; Peng CT; Wu KH; Tsai CH
    Hemoglobin; 2006; 30(2):215-8. PubMed ID: 16798646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac iron overload in sickle-cell disease.
    Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
    Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
    Vitrano A; Calvaruso G; Tesé L; Gioia F; Cassarà F; Campisi S; Butera F; Commendatore V; Rizzo M; Santoro V; Cigna V; Quota A; Bagnato S; Argento C; Fidone C; Schembari D; Gerardi C; Barbiera F; Bellisssima G; Giugno G; Polizzi G; Rosso R; Abbate G; Caruso V; Chiodi E; Gamberini MR; Giorgi B; Putti MC; Filosa A; De Ritis MR; Oliva E; Arcadi N; Fustaneo M; Mistretta L; Di Maggio R; Sacco M; Veronica DS; Giangreco A; Maggio A
    Eur J Haematol; 2016 Oct; 97(4):361-70. PubMed ID: 26818147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
    Vitrano A; Sacco M; Rosso R; Quota A; Fiorino D; Oliva E; Gerardi C; Roccamo G; Spadola V; Filosa A; Tesé L; Calvaruso G; Pitrolo L; Mistretta L; Cassarà F; Di Maggio R; Maggio A
    Eur J Haematol; 2018 Feb; 100(2):124-130. PubMed ID: 29094403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
    Rose C; Vandevenne P; Bourgeois E; Cambier N; Ernst O
    Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement and mapping of liver iron concentrations using magnetic resonance imaging.
    St Pierre TG; Clark PR; Chua-Anusorn W
    Ann N Y Acad Sci; 2005; 1054():379-85. PubMed ID: 16339686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
    Ricchi P; Meloni A; Spasiano A; Costantini S; Pepe A; Cinque P; Filosa A
    Br J Haematol; 2018 Mar; 180(5):721-726. PubMed ID: 29363758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
    Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term Erythrocytapheresis Is Associated With Reduced Liver Iron Concentration in Sickle Cell Disease.
    Myers SN; Eid R; Myers J; Bertolone S; Panigrahi A; Mullinax J; Raj AB
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):22-6. PubMed ID: 26650249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron overload and chronically transfused patients: numbers, scales, and clinical research.
    Callea F
    Am J Hematol; 2009 Aug; 84(8):471-2. PubMed ID: 19565648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.